Header cover image

Argentinian (MERVAL) Pharma Industry Analysis

UpdatedAug 30, 2025
DataAggregated Company Financials
Companies2
  • 7D-7.8%
  • 3M-20.3%
  • 1Y23.9%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 7.3%, driven by a pullback from Laboratorios RichmondC.I.F of 8.2%. Meanwhile, Instituto Rosenbusch actually outperformed within the industry, gaining 5.6% in the last week. This takes the industry's 12 month performance to a gain of 24%.

Industry Valuation and Performance

Has the Argentinian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 31 Aug 2025AR$97.6bAR$104.5bAR$9.0b8x10.8x0.9x
Tue, 29 Jul 2025AR$121.3bAR$102.7bAR$16.3b6x7.5x1.2x
Thu, 26 Jun 2025AR$121.2bAR$104.7bAR$17.4b5.9x7x1.2x
Sat, 24 May 2025AR$123.6bAR$104.7bAR$17.4b6.3x7.1x1.2x
Mon, 21 Apr 2025AR$121.1bAR$100.1bAR$22.4b4.9x5.4x1.2x
Wed, 19 Mar 2025AR$142.2bAR$96.9bAR$24.8b4.9x5.7x1.5x
Fri, 14 Feb 2025AR$126.8bAR$42.6bAR$18.2b6x7x3x
Sun, 12 Jan 2025AR$146.0bAR$42.6bAR$18.2b6.6x8x3.4x
Tue, 10 Dec 2024AR$140.0bAR$42.6bAR$18.2b6.6x7.7x3.3x
Thu, 07 Nov 2024AR$132.8bAR$40.7bAR$4.6b21.5x29.2x3.3x
Sat, 05 Oct 2024AR$79.0bAR$40.7bAR$4.6b12.5x17.4x1.9x
Mon, 02 Sep 2024AR$81.4bAR$42.3bAR$4.3b13.3x18.8x1.9x
Wed, 31 Jul 2024AR$80.0bAR$41.1b-AR$3,264,658,797.003.9x-24.5x1.9x
Fri, 28 Jun 2024AR$84.1bAR$41.1b-AR$3,264,658,797.005.2x-25.8x2x
Sun, 26 May 2024AR$87.9bAR$41.1b-AR$3,264,658,797.004.9x-26.9x2.1x
Tue, 23 Apr 2024AR$74.8bAR$43.6b-AR$10,287,966,966.007.4x-7.3x1.7x
Thu, 21 Mar 2024AR$71.5bAR$9.6b-AR$4,702,241,388.0045x-15.2x7.4x
Sat, 17 Feb 2024AR$88.8bAR$9.6b-AR$4,702,241,388.0066x-18.9x9.2x
Mon, 15 Jan 2024AR$65.7bAR$10.3b-AR$4,704,193,685.0036.8x-14x6.4x
Wed, 13 Dec 2023AR$64.8bAR$10.3b-AR$4,704,193,685.0035.7x-13.8x6.3x
Fri, 10 Nov 2023AR$56.2bAR$13.0b-AR$2,496,856,221.00n/a-22.5x4.3x
Sun, 08 Oct 2023AR$46.1bAR$13.0b-AR$2,496,856,221.00n/a-18.5x3.5x
Tue, 05 Sep 2023AR$48.4bAR$18.8b-AR$150,001,147.0018.4x-322.9x2.6x
Thu, 03 Aug 2023AR$43.0bAR$18.8b-AR$150,001,147.0013.8x-286.6x2.3x
Sat, 01 Jul 2023AR$42.5bAR$18.8b-AR$150,001,147.0013.8x-283.6x2.3x
Mon, 29 May 2023AR$39.9bAR$19.1bAR$209.1m128.2x191x2.1x
Wed, 26 Apr 2023AR$33.3bAR$19.1bAR$209.1m106.9x159.4x1.7x
Fri, 24 Mar 2023AR$32.0bAR$19.1bAR$209.1m102.6x153.1x1.7x
Sun, 19 Feb 2023AR$32.1bAR$13.7bAR$1.5b17.2x20.7x2.3x
Tue, 17 Jan 2023AR$33.9bAR$13.7bAR$1.5b17.5x21.9x2.5x
Thu, 15 Dec 2022AR$28.9bAR$13.8bAR$1.5b18.9x19.2x2.1x
Sat, 12 Nov 2022AR$27.0bAR$19.6bAR$1.4b19.4x19.8x1.4x
Mon, 10 Oct 2022AR$28.1bAR$19.7bAR$1.4b24.5x20.4x1.4x
Wed, 07 Sep 2022AR$24.1bAR$17.8bAR$987.0m27.7x24.4x1.3x
Price to Earnings Ratio

24.4x


Total Market Cap: AR$24.1bTotal Earnings: AR$987.0mTotal Revenue: AR$17.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Argentinian Pharma Industry Price to Earnings3Y Average -8.7x202320242025
Current Industry PE
    There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 109% per year over the last three years.
  • Revenues for these companies have grown 80% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Argentinian Pharma compare with similar industries?

AR Market-5.63%
Healthcare-7.78%
Pharma-7.78%
Pharma-7.78%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News